drugset / Trial / NCT06282510
Nasal Antisepsis for C. Auris Prevention
Phase 4
Recruiting
120 enrolled
Mary K Hayden
RML Specialty Hospital · collabRush University Medical Center · collab
RandomizedParallel-groupSingle-blindPrevention
Summary
This is a randomized, controlled, open-label trial of effect of 10% povidone iodine intranasal antisepsis on the detection of Candida auris.
Timeline
- Start
- 2024-01-29
- Primary completion
- 2026-12
- Completion
- 2028-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Povidone-Iodine | Other / unclassified | 10 % | Intranasal |